Related references
Note: Only part of the references are listed.Vancomycin for the treatment of Clostridium difficile infection:: For whom is this expensive bullet really magic?
Jacques Pepin
CLINICAL INFECTIOUS DISEASES (2008)
Comparison of clinical and microbiological response to treatment of Clostridium difficile associated disease with metronidazole and vancomycin
Wafa N. Al-Nassir et al.
CLINICAL INFECTIOUS DISEASES (2008)
Emergence of reduced susceptibility to metronidazole in Clostridium difficile
Simon D. Baines et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Use of highly discriminatory fingerprinting to analyze clusters of Clostridium difficile infection cases due to epidemic ribotype 027 strains
W. N. Fawley et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
The emerging infectious challenge of clostridium difficile-associated disease in Massachusetts hospitals: Clinical and economic consequences
Judith A. O'Brien et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2007)
A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile -: Associated diarrhea, stratified by disease severity
Fred A. Zar et al.
CLINICAL INFECTIOUS DISEASES (2007)
Effect of metronidazole on growth and toxin production by epidemic Clostridium difficile PCR ribotypes 001 and 027 in a human gut model
Jane Freeman et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Tigecycline does not induce proliferation or cytotoxin production by epidemic Clostridium difficile strains in a human gut model
Simon D. Baines et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec
J Pépin et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2005)
Comparison of the efficacy of ramoplanin and vancomycin in both in vitro and in vivo models of clindamycin-induced Clostridium difficile infection
J Freeman et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole
DM Musher et al.
CLINICAL INFECTIOUS DISEASES (2005)
Effects of piperacillin/tazobactam on Clostridium difficile growth and toxin production in a human gut model
SD Baines et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Effects of cefotaxime and desacetylcefotaxime upon Clostridium difficile proliferation and toxin production in a triple-stage chemostat model of the human gut
J Freeman et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Hospital disinfectants and spore formation by Clostridium difficile
MH Wilcox et al.
LANCET (2000)
Share Paper
